Check urinary and sexual function after rectal cancer surgery
Part of Cancer, Digestive system clinical trials.
This study looks at how a specific rectal surgery (laparoscopic total mesorectum excision) affects urinary and sexual function after the operation. It may help patients by tracking what to expect and which factors relate to better recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 to 70 and can give informed consent
- Your rectal cancer is located 6 to 12 cm from the anal opening (measured with a rigid scope)
- Rectal cancer must be confirmed by biopsy
- Your cancer stage before treatment is cT1-3a N0 M0 (no spread to nodes or distant organs)
- Your surgery is expected to fully remove the tumor (R0 resection expected)
- Before surgery, your urinary function and erections/ejaculation are in the lowest-risk group (grade I)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at patient-reported outcomes—how you feel and function—after surgery for rectal cancer. It may help doctors better understand recovery and well-being after different surgical approaches and treatments.
This study compares two ways of performing rectal cancer surgery: robotic surgery and a newer technique called TaTME (transanal total mesorectal excision). It aims to see which approach has better outcomes for patients. If you're having surgery for rectal cancer, this trial might help you get access to advanced surgical options.
This study looks at how people feel and their quality of life after surgery for lower rectal cancer. The goal is to understand what life is like years after the operation, which can help future patients know what to expect.
This trial compares two different surgery approaches for early-stage rectal cancer (T2N0M0) that is close to the anus. It tests whether a less invasive local removal followed by radiation works as well as more extensive surgery (total mesorectal excision).
This trial studies how to improve bowel symptoms in people treated for rectal cancer. It tests personalized care plans and looks at different factors that may contribute to bowel problems after surgery or a watch-and-wait approach.
This study tests a new combination of treatment before surgery for high-risk rectal cancer. It combines a shorter course of radiation with chemotherapy and immunotherapy (which helps your immune system fight cancer) to see if it shrinks the tumor and improves outcomes.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.